108-29-2 | Gamma-valerolactone

Packsize	Purity	Availability	Price	Discounted Price
25g	98%	in stock	$13.00	$9.00
100g	98%	in stock	$20.00	$14.00
500g	98%	in stock	$39.00	$27.00
1000g	98%	in stock	$73.00	$51.00

Description

• Catalog Number: AB46202
• Chemical Name: Gamma-valerolactone
• CAS Number: 108-29-2
• Molecular Formula: C5H8O2
• Molecular Weight: 100.1158
• MDL Number: MFCD00005400
• SMILES: CC1CCC(=O)O1
• NSC Number: 33700

Computed Properties

• Complexity: 88.1
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• Undefined Atom Stereocenter Count: 1
• XLogP3: 0.6

Literature

• Development of heterogeneous catalysts for the conversion of levulinic acid to γ-valerolactone.

  ChemSusChem 20120901

• Gamma butyrolactone (GBL) and gamma valerolactone (GVL): similarities and differences in their effects on the acoustic startle reflex and the conditioned enhancement of startle in the rat.

  Pharmacology, biochemistry, and behavior 20120601

• Production of aromatic hydrocarbons through catalytic pyrolysis of γ-valerolactone from biomass.

  Bioresource technology 20120601

• 5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.

  Bioorganic & medicinal chemistry letters 20120101

• Conversion of biomass-derived levulinate and formate esters into γ-valerolactone over supported gold catalysts.

  ChemSusChem 20111216

• Liquid-phase catalytic transfer hydrogenation and cyclization of levulinic acid and its esters to γ-valerolactone over metal oxide catalysts.

  Chemical communications (Cambridge, England) 20111128

• Selective homogeneous hydrogenation of biogenic carboxylic acids with [Ru(TriPhos)H]+: a mechanistic study.

  Journal of the American Chemical Society 20110914

• Hydrogen-independent reductive transformation of carbohydrate biomass into γ-valerolactone and pyrrolidone derivatives with supported gold catalysts.

  Angewandte Chemie (International ed. in English) 20110816

• Comparison of fermented soybean paste (Doenjang) prepared by different methods based on profiling of volatile compounds.

  Journal of food science 20110401

• Reactive extraction of levulinate esters and conversion to γ-valerolactone for production of liquid fuels.

  ChemSusChem 20110321

• Simultaneous determination of γ-Hydroxybutyrate (GHB) and its analogues (GBL, 1.4-BD, GVL) in whole blood and urine by liquid chromatography coupled to tandem mass spectrometry.

  Journal of analytical toxicology 20110101

• Antioxidative activity of microbial metabolites of (-)-epigallocatechin gallate produced in rat intestines.

  Bioscience, biotechnology, and biochemistry 20110101

• γ-Valerolactone ring-opening and decarboxylation over SiO2/Al2O3 in the presence of water.

  Langmuir : the ACS journal of surfaces and colloids 20101102

• Conversion of levulinic acid and formic acid into γ-valerolactone over heterogeneous catalysts.

  ChemSusChem 20101025

• Chemistry. Connecting biomass and petroleum processing with a chemical bridge.

  Science (New York, N.Y.) 20100730

• Absolute configuration of isoeichlerialactone.

  Acta crystallographica. Section E, Structure reports online 20100401

• Integrated catalytic conversion of gamma-valerolactone to liquid alkenes for transportation fuels.

  Science (New York, N.Y.) 20100226

• A methodology to estimate concentration profiles from two-dimensional covariance spectroscopy applied to kinetic data.

  Applied spectroscopy 20100201

• Bioavailability and catabolism of green tea flavan-3-ols in humans.

  Nutrition (Burbank, Los Angeles County, Calif.) 20100101

• Palladium-catalyzed decarboxylative [4 + 3] cyclization of gamma-methylidene-delta-valerolactones with 1,1-dicyanocyclopropanes.

  Organic letters 20091217

• Characterization of two lactones in liquid phase: an experimental and computational approach.

  Physical chemistry chemical physics : PCCP 20090814

• MCR-ALS for sequential estimation of FTIR-ATR spectra to resolve a curing process using global phase angle convergence criterion.

  Analytica chimica acta 20090529

• Catalytic conversion of biomass-derived carbohydrates into gamma-valerolactone without using an external H2 supply.

  Angewandte Chemie (International ed. in English) 20090101

• Block copolymers for drug solubilisation: relative hydrophobicities of polyether and polyester micelle-core-forming blocks.

  International journal of pharmaceutics 20071210

• Maximising opportunities in supercritical chemistry: the continuous conversion of levulinic acid to gamma-valerolactone in CO(2).

  Chemical communications (Cambridge, England) 20071128

• Towards 'bio-based' Nylon: conversion of gamma-valerolactone to methyl pentenoate under catalytic distillation conditions.

  Chemical communications (Cambridge, England) 20070907

• Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases.

  Journal of analytical toxicology 20070101

• 'Ionic carbenes': synthesis, structural characterization, and reactivity of rare-Earth metal methylidene complexes.

  Journal of the American Chemical Society 20060726

• Difference in the volatile composition of pine-mushrooms (Tricholoma matsutake Sing.) according to their grades.

  Journal of agricultural and food chemistry 20060628

• Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

  Journal of medicinal chemistry 20050602

• A theoretical study on the origin of pi-facial stereoselectivity in the alkylation of enolates derived from 4-substituted gamma-butyrolactones.

  Journal of the American Chemical Society 20050323

• Sequential arrangement of gamma-valerolactone enantiomers enclathrated in cholic acid channels as studied by 13C solid-state NMR: elucidation of the optical resolution mechanism.

  Journal of the American Chemical Society 20040721

• Phenol and lactone receptors in the distal sensilla of the Haller's organ in Ixodes ricinus ticks and their possible role in host perception.

  Experimental & applied acarology 20040101

• Biosynthesis and local sequence specific degradation of poly(3-hydroxyvalerate-co-4-hydroxybutyrate) in Hydrogenophaga pseudoflava.

  Biomacromolecules 20030101

• Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

  Clinical pharmacokinetics 20030101

• Versatile 8-oxabicyclo[3.2.1]oct-6-en-3-one: stereoselective methodology for generating C-glycosides, delta-valerolactones, and polyacetate segments.

  Organic letters 20010125